Does the media prefer SBC or TALK?

In the previous week, SBC Medical Group had 1 more articles in the media than Talkspace. MarketBeat recorded 4 mentions for SBC Medical Group and 3 mentions for Talkspace. SBC Medical Group's average media sentiment score of 0.76 beat Talkspace's score of 0.76 indicating that SBC Medical Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SBC Medical Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Talkspace 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to CSTL or SBC?

In the previous week, Castle Biosciences and Castle Biosciences both had 4 articles in the media. SBC Medical Group's average media sentiment score of 0.76 beat Castle Biosciences' score of -0.23 indicating that SBC Medical Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Castle Biosciences 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SBC Medical Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to SBC or FLGT?

In the previous week, Fulgent Genetics had 1 more articles in the media than SBC Medical Group. MarketBeat recorded 5 mentions for Fulgent Genetics and 4 mentions for SBC Medical Group. Fulgent Genetics' average media sentiment score of 0.90 beat SBC Medical Group's score of 0.76 indicating that Fulgent Genetics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SBC Medical Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fulgent Genetics 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor TOI or SBC?

In the previous week, Oncology Institute had 10 more articles in the media than SBC Medical Group. MarketBeat recorded 14 mentions for Oncology Institute and 4 mentions for SBC Medical Group. Oncology Institute's average media sentiment score of 0.95 beat SBC Medical Group's score of 0.76 indicating that Oncology Institute is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oncology Institute 4 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SBC Medical Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

SBC Medical Group (SBC) Competitors

$3.10 +0.13 (+4.38%)

Closing price 04:00 PM Eastern

Extended Trading

$3.10 0.00 (0.00%)

As of 06:18 PM Eastern

Compare

SBC vs. LMRI, TALK, CSTL, FLGT, and TOI

Should you buy SBC Medical Group stock or one of its competitors? MarketBeat compares SBC Medical Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SBC Medical Group include Lumexa Imaging (LMRI), Talkspace (TALK), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), and Oncology Institute (TOI). These companies are all part of the "healthcare" industry.

How does SBC Medical Group compare to Lumexa Imaging?

Lumexa Imaging (NASDAQ:LMRI) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.

In the previous week, SBC Medical Group had 3 more articles in the media than Lumexa Imaging. MarketBeat recorded 4 mentions for SBC Medical Group and 1 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 1.44 beat SBC Medical Group's score of 0.76 indicating that Lumexa Imaging is being referred to more favorably in the media.

Company	Overall Sentiment
Lumexa Imaging	Positive
SBC Medical Group	Positive

SBC Medical Group has lower revenue, but higher earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lumexa Imaging	$267.73M	4.00	-$47.10M	-$0.59	N/A
SBC Medical Group	$173.61M	1.83	$50.99M	$0.39	7.95

60.8% of SBC Medical Group shares are owned by institutional investors. 0.7% of Lumexa Imaging shares are owned by insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Lumexa Imaging presently has a consensus target price of $16.00, indicating a potential upside of 43.50%. SBC Medical Group has a consensus target price of $8.50, indicating a potential upside of 174.19%. Given SBC Medical Group's higher possible upside, analysts clearly believe SBC Medical Group is more favorable than Lumexa Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

SBC Medical Group has a net margin of 24.09% compared to Lumexa Imaging's net margin of 0.00%. SBC Medical Group's return on equity of 15.90% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lumexa Imaging	N/A	N/A	N/A
SBC Medical Group	24.09%	15.90%	11.61%

Summary

SBC Medical Group beats Lumexa Imaging on 11 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to Talkspace?

SBC Medical Group (NASDAQ:SBC) and Talkspace (NASDAQ:TALK) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk.

SBC Medical Group currently has a consensus target price of $8.50, suggesting a potential upside of 174.19%. Talkspace has a consensus target price of $5.56, suggesting a potential upside of 6.36%. Given SBC Medical Group's stronger consensus rating and higher possible upside, analysts plainly believe SBC Medical Group is more favorable than Talkspace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Talkspace	1 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, SBC Medical Group had 1 more articles in the media than Talkspace. MarketBeat recorded 4 mentions for SBC Medical Group and 3 mentions for Talkspace. SBC Medical Group's average media sentiment score of 0.76 beat Talkspace's score of 0.76 indicating that SBC Medical Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SBC Medical Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Talkspace	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

60.8% of SBC Medical Group shares are held by institutional investors. Comparatively, 57.4% of Talkspace shares are held by institutional investors. 81.7% of SBC Medical Group shares are held by company insiders. Comparatively, 23.5% of Talkspace shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

SBC Medical Group has a beta of 0.6, meaning that its share price is 40% less volatile than the broader market. Comparatively, Talkspace has a beta of 1.07, meaning that its share price is 7% more volatile than the broader market.

SBC Medical Group has higher earnings, but lower revenue than Talkspace. SBC Medical Group is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SBC Medical Group	$173.61M	1.83	$50.99M	$0.39	7.95
Talkspace	$228.87M	3.83	$7.79M	$0.01	523.00

SBC Medical Group has a net margin of 24.09% compared to Talkspace's net margin of 0.49%. SBC Medical Group's return on equity of 15.90% beat Talkspace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SBC Medical Group	24.09%	15.90%	11.61%
Talkspace	0.49%	1.03%	0.88%

Summary

SBC Medical Group beats Talkspace on 12 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to Castle Biosciences?

Castle Biosciences (NASDAQ:CSTL) and SBC Medical Group (NASDAQ:SBC) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations.

SBC Medical Group has a net margin of 24.09% compared to Castle Biosciences' net margin of -3.78%. SBC Medical Group's return on equity of 15.90% beat Castle Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Castle Biosciences	-3.78%	-2.77%	-2.30%
SBC Medical Group	24.09%	15.90%	11.61%

Castle Biosciences has a beta of 1, indicating that its stock price has a similar volatility profile to the broader market.Comparatively, SBC Medical Group has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market.

Castle Biosciences presently has a consensus target price of $42.43, indicating a potential upside of 84.63%. SBC Medical Group has a consensus target price of $8.50, indicating a potential upside of 174.19%. Given SBC Medical Group's higher probable upside, analysts clearly believe SBC Medical Group is more favorable than Castle Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Castle Biosciences	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

92.6% of Castle Biosciences shares are owned by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are owned by institutional investors. 6.1% of Castle Biosciences shares are owned by company insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

SBC Medical Group has lower revenue, but higher earnings than Castle Biosciences. Castle Biosciences is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Castle Biosciences	$344.23M	2.02	-$24.16M	-$0.44	N/A
SBC Medical Group	$173.61M	1.83	$50.99M	$0.39	7.95

In the previous week, Castle Biosciences and Castle Biosciences both had 4 articles in the media. SBC Medical Group's average media sentiment score of 0.76 beat Castle Biosciences' score of -0.23 indicating that SBC Medical Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Castle Biosciences	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SBC Medical Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

SBC Medical Group beats Castle Biosciences on 9 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to Fulgent Genetics?

SBC Medical Group (NASDAQ:SBC) and Fulgent Genetics (NASDAQ:FLGT) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, media sentiment, analyst recommendations, institutional ownership and dividends.

In the previous week, Fulgent Genetics had 1 more articles in the media than SBC Medical Group. MarketBeat recorded 5 mentions for Fulgent Genetics and 4 mentions for SBC Medical Group. Fulgent Genetics' average media sentiment score of 0.90 beat SBC Medical Group's score of 0.76 indicating that Fulgent Genetics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SBC Medical Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fulgent Genetics	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

SBC Medical Group has higher earnings, but lower revenue than Fulgent Genetics. Fulgent Genetics is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SBC Medical Group	$173.61M	1.83	$50.99M	$0.39	7.95
Fulgent Genetics	$322.67M	1.80	-$60.51M	-$2.39	N/A

60.8% of SBC Medical Group shares are owned by institutional investors. Comparatively, 48.1% of Fulgent Genetics shares are owned by institutional investors. 81.7% of SBC Medical Group shares are owned by insiders. Comparatively, 36.2% of Fulgent Genetics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

SBC Medical Group has a net margin of 24.09% compared to Fulgent Genetics' net margin of -23.04%. SBC Medical Group's return on equity of 15.90% beat Fulgent Genetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SBC Medical Group	24.09%	15.90%	11.61%
Fulgent Genetics	-23.04%	-3.24%	-2.97%

SBC Medical Group has a beta of 0.6, meaning that its share price is 40% less volatile than the broader market. Comparatively, Fulgent Genetics has a beta of 0.89, meaning that its share price is 11% less volatile than the broader market.

SBC Medical Group currently has a consensus target price of $8.50, indicating a potential upside of 174.19%. Fulgent Genetics has a consensus target price of $27.00, indicating a potential upside of 32.22%. Given SBC Medical Group's stronger consensus rating and higher possible upside, research analysts plainly believe SBC Medical Group is more favorable than Fulgent Genetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Fulgent Genetics	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Summary

SBC Medical Group beats Fulgent Genetics on 11 of the 15 factors compared between the two stocks.

How does SBC Medical Group compare to Oncology Institute?

Oncology Institute (NASDAQ:TOI) and SBC Medical Group (NASDAQ:SBC) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability.

36.9% of Oncology Institute shares are held by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are held by institutional investors. 4.4% of Oncology Institute shares are held by insiders. Comparatively, 81.7% of SBC Medical Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Oncology Institute had 10 more articles in the media than SBC Medical Group. MarketBeat recorded 14 mentions for Oncology Institute and 4 mentions for SBC Medical Group. Oncology Institute's average media sentiment score of 0.95 beat SBC Medical Group's score of 0.76 indicating that Oncology Institute is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Oncology Institute	4 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SBC Medical Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Oncology Institute currently has a consensus target price of $8.40, indicating a potential upside of 34.40%. SBC Medical Group has a consensus target price of $8.50, indicating a potential upside of 174.19%. Given SBC Medical Group's higher probable upside, analysts plainly believe SBC Medical Group is more favorable than Oncology Institute.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oncology Institute	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

SBC Medical Group has lower revenue, but higher earnings than Oncology Institute. Oncology Institute is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oncology Institute	$502.73M	1.23	-$60.61M	-$0.37	N/A
SBC Medical Group	$173.61M	1.83	$50.99M	$0.39	7.95

Oncology Institute has a beta of 0.36, suggesting that its share price is 64% less volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market.

SBC Medical Group has a net margin of 24.09% compared to Oncology Institute's net margin of -7.42%. SBC Medical Group's return on equity of 15.90% beat Oncology Institute's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oncology Institute	-7.42%	N/A	-24.68%
SBC Medical Group	24.09%	15.90%	11.61%

Summary

SBC Medical Group beats Oncology Institute on 11 of the 16 factors compared between the two stocks.

Get SBC Medical Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SBC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SBC vs. The Competition

Export

Metric	SBC Medical Group	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$304.65M	$9.60B	$7.06B	$12.61B
Dividend Yield	N/A	1.62%	2.68%	8.01%
P/E Ratio	7.95	26.00	27.15	24.26
Price / Sales	1.83	17.41	526.89	94.41
Price / Cash	5.68	14.81	29.22	49.36
Price / Book	1.21	6.05	10.75	6.29
Net Income	$50.99M	$177.20M	$3.58B	$330.66M
7 Day Performance	0.65%	-2.82%	-2.10%	-2.41%
1 Month Performance	8.01%	6.96%	3.32%	-0.64%
1 Year Performance	-38.61%	11.64%	28.17%	20.09%

SBC Medical Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SBC SBC Medical Group	3.8047 of 5 stars	$3.10 +4.4%	$8.50 +174.2%	-41.2%	$304.65M	$173.61M	7.95	N/A
LMRI Lumexa Imaging	4.5686 of 5 stars	$12.16 -1.0%	$16.00 +31.6%	N/A	$1.17B	$267.73M	N/A	5,019	News Coverage Positive News
TALK Talkspace	2.0782 of 5 stars	$5.22 +0.1%	$5.56 +6.7%	+98.1%	$873.57M	$228.87M	522.02	500
CSTL Castle Biosciences	3.1508 of 5 stars	$23.70 -0.5%	$42.43 +79.0%	+20.7%	$720.64M	$344.23M	N/A	540
FLGT Fulgent Genetics	3.2239 of 5 stars	$20.86 -2.5%	$27.00 +29.5%	+6.6%	$590.77M	$320.35M	N/A	1,315	News Coverage Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SBC) was last updated on 7/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SBC Medical Group (SBC) Competitors

SBC vs. LMRI, TALK, CSTL, FLGT, and TOI

How does SBC Medical Group compare to Lumexa Imaging?

Summary

How does SBC Medical Group compare to Talkspace?

Summary

How does SBC Medical Group compare to Castle Biosciences?

Summary

How does SBC Medical Group compare to Fulgent Genetics?

Summary

How does SBC Medical Group compare to Oncology Institute?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SBC vs. The Competition

SBC Medical Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SBC Medical Group (SBC) Competitors

SBC vs. LMRI, TALK, CSTL, FLGT, and TOI

How does SBC Medical Group compare to Lumexa Imaging?

Does the media favor LMRI or SBC?

Which has better earnings & valuation, LMRI or SBC?

Do insiders and institutionals believe in LMRI or SBC?

Do analysts rate LMRI or SBC?

Is LMRI or SBC more profitable?

Summary

How does SBC Medical Group compare to Talkspace?

Do analysts recommend SBC or TALK?

Does the media prefer SBC or TALK?

Do institutionals and insiders hold more shares of SBC or TALK?

Which has more volatility and risk, SBC or TALK?

Which has better earnings and valuation, SBC or TALK?

Is SBC or TALK more profitable?

Summary

How does SBC Medical Group compare to Castle Biosciences?

Is CSTL or SBC more profitable?

Which has more risk and volatility, CSTL or SBC?

Do analysts recommend CSTL or SBC?

Do insiders & institutionals have more ownership in CSTL or SBC?

Which has higher earnings & valuation, CSTL or SBC?

Does the media refer more to CSTL or SBC?

Summary

How does SBC Medical Group compare to Fulgent Genetics?

Does the media refer more to SBC or FLGT?

Which has preferable valuation and earnings, SBC or FLGT?

Do insiders & institutionals have more ownership in SBC or FLGT?

Is SBC or FLGT more profitable?

Which has more volatility and risk, SBC or FLGT?

Do analysts rate SBC or FLGT?

Summary

How does SBC Medical Group compare to Oncology Institute?

Do insiders & institutionals have more ownership in TOI or SBC?

Does the media favor TOI or SBC?

Do analysts recommend TOI or SBC?

Which has preferable valuation & earnings, TOI or SBC?

Which has more risk and volatility, TOI or SBC?

Is TOI or SBC more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SBC vs. The Competition

SBC Medical Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools